الولايات المتحدة · مجلات اقتصادية · Quartz

Merck topped estimates and raised its profit forecast as cancer drug injection took off

نشره Quartz · الولايات المتحدة منذ 1 س

Adjusted profit forecast moves to $2.77 to $2.82 a share from $2.66 to $2.76 as Keytruda Qlex sales reach $830 million

اقرأ المقال كاملًا على Quartz سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (qz.com)

يستحق القراءة أيضًا

Halloween Reveals a Scary Mistake Even Smart Entrepreneurs Make

ECB’s president Christine Lagarde is resigning nine months early, giving EU leaders a chance to pick a successor before France’s elections

Your Adjustable-Rate Mortgage Is About to Reset. Here Are 5 Moves to Make Now

Purple is everywhere in fintech. This bank rebranded but kept the color

DoorDash strikes $17B deal for rival Instacart in bets on grocery delivery

D.C.'s foie gras ban could face a costly court fight